EP 3923960 A1 20211222 - STEM CELL THERAPY FOR LACRIMAL GLAND DYSFUNCTION
Title (en)
STEM CELL THERAPY FOR LACRIMAL GLAND DYSFUNCTION
Title (de)
STAMMZELLTHERAPIE FÜR TRÄNENDRÜSENFUNKTIONSSTÖRUNGEN
Title (fr)
THÉRAPIE À BASE DE CELLULES SOUCHES POUR LE TRAITEMENT D'UN DYSFONCTIONNEMENT DES GLANDES LACRYMALES
Publication
Application
Priority
- EP 19157430 A 20190215
- EP 2020053876 W 20200214
Abstract (en)
[origin: WO2020165404A1] Described herein are compositions comprising allogeneic adipose-derived stem cells and their use in treating or preventing lacrimal and/or meibomian gland dysfunction, e.g., in dry eye diseases, such as aqueous-deficient dry eye disease.
IPC 8 full level
A61K 35/12 (2015.01); A61P 27/02 (2006.01)
CPC (source: EP)
A61K 35/12 (2013.01); A61P 27/02 (2017.12)
Citation (search report)
See references of WO 2020165404A1
Designated contracting state (EPC)
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated extension state (EPC)
BA ME
DOCDB simple family (publication)
DOCDB simple family (application)
EP 2020053876 W 20200214; EP 20704038 A 20200214